We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current KMDA market cap is 268.59M. The company's latest EPS is USD 0.1847 and P/E is 32.43.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 30.71M | 37.44M | 38.09M | 37.74M | 42.47M |
| Operating Income | 289k | 2.63M | 4.37M | 4.04M | 5.64M |
| Net Income | -1.81M | 1.81M | 3.22M | 2.37M | 4.43M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 127.19M | 133.25M | 103.64M | 129.34M | 142.52M |
| Operating Income | 22.78M | 19.24M | -696k | 4.53M | 10.06M |
| Net Income | 22.25M | 17.14M | -2.23M | -2.32M | 8.28M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 316.8M | 314.39M | 337.06M | 343.17M | 351.04M |
| Total Liabilities | 141.99M | 137.64M | 98.67M | 96.66M | 99.89M |
| Total Equity | 174.81M | 176.75M | 238.39M | 246.51M | 251.15M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 173.8M | 210.67M | 318.67M | 322.38M | 354.91M |
| Total Liabilities | 38.48M | 32.03M | 141.84M | 146.36M | 110.89M |
| Total Equity | 135.32M | 178.64M | 176.82M | 176.02M | 244.02M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.85M | 1.82M | 921k | 1.02M | 13.96M |
| Investing | -1.09M | -1.05M | -1.73M | -2.68M | -3.01M |
| Financing | -2.88M | -5.86M | 31.3M | -5.74M | -2.68M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 27.57M | 19.11M | -8.82M | 28.59M | 4.32M |
| Investing | -564k | -13.13M | -61.05M | -3.78M | -5.84M |
| Financing | -1.53M | 23.36M | 18.59M | -9.34M | 22.68M |
| Market Cap | 268.59M |
| Price to Earnings Ratio | 32.43 |
| Price to Sales Ratio | 1.88 |
| Price to Cash Ratio | 4.83 |
| Price to Book Ratio | 1.1 |
| Dividend Yield | - |
| Shares Outstanding | 44.84M |
| Average Volume (1 week) | 72.04k |
| Average Volume (1 Month) | 33.12k |
| 52 Week Change | 26.11% |
| 52 Week High | 6.5291 |
| 52 Week Low | 4.58 |
| Spread (Intraday) | 0.14 (2.31%) |
| Company Name | Kamada Ltd |
| Address |
2 holzman st, science park rehovot, center 7670402 |
| Website | https://www.kamada.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
